Panagene Inc (046210) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Panagene Inc (046210) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.17 Million ≈ $31.29K USD) by net assets (₩77.27 Billion ≈ $52.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 046210 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Panagene Inc - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Panagene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Panagene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panagene Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Duxton Farms Ltd AU:DBF	-0.113x
Cowealth Medical Holding Co Ltd TWO:4745	-0.095x
Radana Bhaskara Finance Tbk JK:HDFA	-0.240x
Momentus Inc NASDAQ:MNTS	-0.614x
Alternative Investment Trust AU:AIQ	0.026x
Acula Technology TWO:3434	0.029x
ELUON Corporation KQ:065440	0.115x
Jembo Cable Company Tbk JK:JECC	-0.109x

Annual Cash Flow Conversion Efficiency for Panagene Inc (2006–2024)

The table below shows the annual cash flow conversion efficiency of Panagene Inc from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 046210 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.04 Billion ≈ $51.53 Million	₩346.54 Million ≈ $234.84K	0.005x	+701.91%
2023-12-31	₩63.57 Billion ≈ $43.08 Million	₩36.13 Million ≈ $24.48K	0.001x	-99.46%
2022-12-31	₩31.69 Billion ≈ $21.48 Million	₩3.36 Billion ≈ $2.28 Million	0.106x	-47.35%
2021-12-31	₩29.84 Billion ≈ $20.22 Million	₩6.01 Billion ≈ $4.07 Million	0.201x	+19.31%
2020-12-31	₩25.07 Billion ≈ $16.99 Million	₩4.23 Billion ≈ $2.87 Million	0.169x	+225.83%
2019-12-31	₩20.20 Billion ≈ $13.69 Million	₩1.05 Billion ≈ $709.60K	0.052x	-17.13%
2018-12-31	₩16.30 Billion ≈ $11.05 Million	₩1.02 Billion ≈ $690.98K	0.063x	+158.64%
2017-12-31	₩19.84 Billion ≈ $13.44 Million	₩-2.12 Billion ≈ $-1.43 Million	-0.107x	-100.63%
2016-12-31	₩21.10 Billion ≈ $14.30 Million	₩-1.12 Billion ≈ $-760.05K	-0.053x	-30.35%
2015-12-31	₩8.91 Billion ≈ $6.04 Million	₩-363.21 Million ≈ $-246.14K	-0.041x	-107.56%
2012-12-31	₩8.92 Billion ≈ $6.05 Million	₩4.81 Billion ≈ $3.26 Million	0.539x	+333.48%
2011-12-31	₩15.94 Billion ≈ $10.80 Million	₩-3.68 Billion ≈ $-2.50 Million	-0.231x	-104.70%
2010-12-31	₩16.66 Billion ≈ $11.29 Million	₩-1.88 Billion ≈ $-1.27 Million	-0.113x	+53.02%
2009-12-31	₩17.92 Billion ≈ $12.15 Million	₩-4.31 Billion ≈ $-2.92 Million	-0.240x	-514.69%
2008-12-31	₩25.88 Billion ≈ $17.54 Million	₩1.50 Billion ≈ $1.02 Million	0.058x	-7.83%
2007-12-31	₩34.14 Billion ≈ $23.14 Million	₩2.15 Billion ≈ $1.45 Million	0.063x	+41.98%
2006-12-31	₩30.94 Billion ≈ $20.97 Million	₩1.37 Billion ≈ $928.01K	0.044x	--

About Panagene Inc

KQ:046210 Korea Biotechnology & Medical Research

Market Cap

$33.71 Million

₩49.75 Billion KRW

Market Cap Rank

#23427 Global

#1567 in Korea

Share Price

₩1548.00

Change (1 day)

-2.64%

52-Week Range

₩1373.00 - ₩2650.00

All Time High

₩12000.00